Results 121 to 130 of about 23,832 (197)

Guideline for the Management Pathway and Quality Control of Breast Cancer Prevention and Treatment in China's Counties

Cancer Innovation, Volume 4, Issue 3, June 2025.
County hospitals bear the primary responsibility for health education, screening, primary diagnosis and treatment, maintenance treatment, management of adverse reactions to antitumor drugs, patient follow‐up, recurrence monitoring, rehabilitation guidance, and two‐way referrals for breast cancer.
Breast Cancer Expert Committee of National Cancer Quality Control Center, Cancer Prevention and Treatment Committee of Healthy China Research Center   +1 more
wiley   +1 more source

THE TEN-YEAR SURVIVORS OF RADICAL MASTECTOMY

, 1933
Frank S. Mathews
openalex   +2 more sources

The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy [PDF]

, 1997
David J. Winchester, Herman R. Menck, David P. Winchester   +2 more
openalex   +1 more source

Biopsy‐derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utility

International Journal of Cancer, Volume 156, Issue 11, Page 2200-2209, 1 June 2025.
What's new? Breast cancer patients often face relapse, sometimes years after initially successful therapy. It would therefore be highly desirable to develop a platform enabling routine assaying of individual efficacy of personalised therapies. Organoids have been proposed as a tool to serve this purpose, but the feasibility of their establishment from ...
Paul Schwerd‐Kleine, Roberto Würth, Tasneem Cheytan, Laura Michel, Verena Thewes, Ewgenija Gutjahr, Huriye Seker‐Cin, Daniel Kazdal, Sarah‐Jane Neuberth, Vera Thiel, Jonas Schwickert, Tim Vorberg, Jennifer Wischhusen, Albrecht Stenzinger, Marc Zapatka, Peter Lichter, Andreas Schneeweiss, Andreas Trumpp, Martin R. Sprick   +18 more
wiley   +1 more source

SKIN REMOVAL IN RADICAL MASTECTOMY

, 1942
William C. White
openalex   +2 more sources

Patient care practices for LGBTQ+ individuals in clinical genetics: A scoping review

Journal of Genetic Counseling, Volume 34, Issue 3, June 2025.
Abstract Individuals who are LGBTQ+ (Lesbian, Gay, Bisexual, Transgender, Queer/Questioning, and/or have a sexual orientations and/or gender identity beyond cisheteronormative conceptions) face systemic barriers to healthcare, leading to significant health inequities. To address these challenges, genetic providers must better understand and inclusively
Kimberly Zayhowski, Kayla Horowitz, Molly Bostrom, Kathleen F. Mittendorf, Megan Kocher, Jehannine (J9) Austin, Ian M. MacFarlane   +6 more
wiley   +1 more source

Treatment related morbidity in breast cancer patients [PDF]

, 2007
Background: Sentinel lymph node biopsy (SLNB) was introduced for staging of the axilla to reduce the number of unnecessary axillary lymph node dissections (ALND’s) and proved to be an accurate and safe procedure to predict metastatic disease in ...
Dijkstra, P.U., Geertzen, J.H.B., Hoekstra, H.J., Rietman, J.S.   +3 more
core   +1 more source

A Descriptive Phenomenological Study of the Women's Experiences From the Suspicion of Breast Cancer to the Initiation of Treatment

Scandinavian Journal of Caring Sciences, Volume 39, Issue 2, June 2025.
ABSTRACT Introduction Breast cancer is the most common malignancy among women worldwide. However, scientific research has paid little attention to the lived experiences of these women, from the onset of concerning symptoms to the initiation of curative treatment.
Rawdha Touzi, Amal Ben Daly, Awatef Ben Amor, Mohamed Ben Dhiab, Christophe Debout   +4 more
wiley   +1 more source

Radical Mastectomy with Parasternal and Supraclavicular Dissection for Mammary Carcinoma

, 1969
E Dahl-Iversen, T. Toblassen
openalex   +2 more sources

Targeting Triple‐Negative Breast Cancer: Resistance Mechanisms and Therapeutic Advancements

Cancer Medicine, Volume 14, Issue 9, May 2025.
ABSTRACT Background Triple‐negative breast cancer (TNBC) is one of the most heterogeneous and menacing forms of breast cancer, with no sustainable cure available in the current treatment landscape. Its lack of targets makes it highly unresponsive to various treatment modalities, which is why chemotherapy continues to be the primary form of treatment ...
Rachana Raman, Shristi Debata, Thirupugal Govindarajan, Praveen Kumar   +3 more
wiley   +1 more source